Publication | Closed Access
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
17
Citations
19
References
2022
Year
Vicagrel had comparable antiplatelet effect and safety to clopidogrel in patients with CAD undergoing PCI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1